
Big prevention blow as women reject one-a-day ARV
The much anticipated pill-a-day HIV prevention tool has been dealt a huge blow after a large scale study '€“ mostly conducted in South Africa '€“ found that most women did not adhere and take the one antiretroviral (ARV) drug daily.












